FY2024 EPS Estimates for Quantum-Si Raised by HC Wainwright

Quantum-Si incorporated (NASDAQ:QSI) – Equities researchers at HC Wainwright upped their FY2024 EPS estimates for Quantum-Si in a report issued on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of ($0.65) for the year, up from their prior estimate of ($0.71). HC Wainwright has a “Buy” rating and a $4.00 price target on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q4 2024 earnings at ($0.18) EPS, Q1 2025 earnings at ($0.18) EPS, Q2 2025 earnings at ($0.17) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.69) EPS, FY2026 earnings at ($0.56) EPS, FY2027 earnings at ($0.42) EPS and FY2028 earnings at ($0.22) EPS.

Separately, Canaccord Genuity Group dropped their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, November 13th.

Quantum-Si Stock Performance

QSI opened at $0.63 on Monday. Quantum-Si has a 1 year low of $0.61 and a 1 year high of $2.43. The company’s 50 day simple moving average is $0.84 and its 200 day simple moving average is $1.08. The stock has a market capitalization of $90.11 million, a PE ratio of -0.99 and a beta of 2.89.

Institutional Trading of Quantum-Si

Several institutional investors have recently added to or reduced their stakes in QSI. Jacobs Levy Equity Management Inc. acquired a new position in Quantum-Si during the 1st quarter valued at about $998,000. Vanguard Group Inc. lifted its holdings in Quantum-Si by 1.6% in the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after purchasing an additional 82,463 shares during the period. Virtu Financial LLC bought a new position in Quantum-Si in the 1st quarter valued at about $98,000. Public Employees Retirement System of Ohio bought a new stake in shares of Quantum-Si during the 1st quarter worth about $27,000. Finally, Bleakley Financial Group LLC bought a new position in shares of Quantum-Si in the first quarter valued at approximately $28,000. Institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.